Clinical Trials Directory

Trials / Completed

CompletedNCT02241772

A Study on the Effects of TA-8995 on Lp(a) in Subjects With Elevated Lp(a)

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
42 (actual)
Sponsor
Xention Ltd · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

A study in males and females with elevated Lp(a) to look at the effects of TA-8995 on Lp(a) levels.

Conditions

Interventions

TypeNameDescription
DRUGTA-8995
DRUGPlacebo

Timeline

Start date
2014-09-01
Primary completion
2015-01-01
Completion
2015-02-01
First posted
2014-09-16
Last updated
2015-02-16

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT02241772. Inclusion in this directory is not an endorsement.